Hongliang Dou

1.2k total citations
26 papers, 881 citations indexed

About

Hongliang Dou is a scholar working on Ophthalmology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Hongliang Dou has authored 26 papers receiving a total of 881 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Ophthalmology, 9 papers in Molecular Biology and 8 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Hongliang Dou's work include Retinal Diseases and Treatments (17 papers), Glaucoma and retinal disorders (7 papers) and Antioxidant Activity and Oxidative Stress (6 papers). Hongliang Dou is often cited by papers focused on Retinal Diseases and Treatments (17 papers), Glaucoma and retinal disorders (7 papers) and Antioxidant Activity and Oxidative Stress (6 papers). Hongliang Dou collaborates with scholars based in China, United States and Bulgaria. Hongliang Dou's co-authors include Yangmu Huang, Xianrong Xu, Xiao-Ming Lin, Zhiyong Zou, Le Ma, Xinrong Lu, Yubei Huang, Yiqun Wu, Mark O.M. Tso and Lin Zhao and has published in prestigious journals such as Nature Communications, PLoS ONE and Scientific Reports.

In The Last Decade

Hongliang Dou

24 papers receiving 853 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hongliang Dou China 14 430 361 327 207 56 26 881
John S. Hurst United States 11 219 0.5× 294 0.8× 195 0.6× 80 0.4× 14 0.3× 19 548
Eui Seok Shin South Korea 16 172 0.4× 404 1.1× 46 0.1× 73 0.4× 69 1.2× 20 872
Ayşegül Çört Türkiye 15 109 0.3× 291 0.8× 75 0.2× 50 0.2× 39 0.7× 25 658
Maria Hytti Finland 15 298 0.7× 447 1.2× 39 0.1× 68 0.3× 71 1.3× 36 796
Show‐Jen Hong Taiwan 15 126 0.3× 254 0.7× 59 0.2× 98 0.5× 15 0.3× 46 588
Hiroshi Izuta Japan 16 117 0.3× 213 0.6× 49 0.1× 57 0.3× 72 1.3× 16 803
Özlem Yıldırım Türkiye 17 93 0.2× 594 1.6× 61 0.2× 44 0.2× 35 0.6× 62 1.1k
Eriko Toda Japan 13 157 0.4× 196 0.5× 67 0.2× 43 0.2× 48 0.9× 14 400
Eveliina Korhonen Finland 15 176 0.4× 291 0.8× 23 0.1× 50 0.2× 44 0.8× 23 549
Daniel A. Gamache United States 17 236 0.5× 197 0.5× 13 0.0× 130 0.6× 24 0.4× 30 1.1k

Countries citing papers authored by Hongliang Dou

Since Specialization
Citations

This map shows the geographic impact of Hongliang Dou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hongliang Dou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hongliang Dou more than expected).

Fields of papers citing papers by Hongliang Dou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hongliang Dou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hongliang Dou. The network helps show where Hongliang Dou may publish in the future.

Co-authorship network of co-authors of Hongliang Dou

This figure shows the co-authorship network connecting the top 25 collaborators of Hongliang Dou. A scholar is included among the top collaborators of Hongliang Dou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hongliang Dou. Hongliang Dou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Chen, Shaohong, Li Wang, Jinlu Zhang, et al.. (2025). Unravelling CYP4V2: Clinical features, genetic insights, pathogenic mechanisms and therapeutic strategies in Bietti crystalline corneoretinal dystrophy. Progress in Retinal and Eye Research. 107. 101377–101377. 2 indexed citations
3.
Meng, Xiang, Fan Zhang, Shaohong Chen, et al.. (2024). In vivo genome editing via CRISPR/Cas9-mediated homology-independent targeted integration for Bietti crystalline corneoretinal dystrophy treatment. Nature Communications. 15(1). 3773–3773. 11 indexed citations
4.
Ma, Baikai, Tong Sun, Yiyun Liu, et al.. (2024). Interpretable Detection of Diabetic Retinopathy, Retinal Vein Occlusion, Age-Related Macular Degeneration, and Other Fundus Conditions. Diagnostics. 14(2). 121–121. 5 indexed citations
5.
Wang, Xiaona, Jing Hong, Pei Zhang, et al.. (2024). Epstein-Barr virus-positive iris diffuse large B-cell lymphoma detected by metagenomic next-generation sequencing. BMC Ophthalmology. 24(1). 99–99. 1 indexed citations
6.
Dou, Hongliang, et al.. (2023). Multimodal Imaging of Choroidal Structural in Torpedo Maculopathy. Frontiers in Medicine. 10. 1085457–1085457. 1 indexed citations
7.
Yang, Jiarui, Yi Ding, Xinglin Wang, et al.. (2023). Predictive value of ellipsoid zone-related angle parameters in primary surgery of large macular hole: a case control study. BMC Ophthalmology. 23(1). 467–467.
8.
Chen, Huijin, et al.. (2020). Effect of intravitreal ranibizumab pretreatment on vitrectomy in young patients with proliferative diabetic retinopathy. Annals of Palliative Medicine. 9(1). 82–89. 13 indexed citations
9.
Hong, Ying, Yuntao Hu, Hongliang Dou, et al.. (2018). Comparison of the safety and efficacy of triple sequential therapy and transscleral cyclophotocoagulation for neovascular glaucoma in the angle-closure stage. Scientific Reports. 8(1). 7074–7074. 2 indexed citations
10.
Yang, Liping, Hui Cui, Hongliang Dou, et al.. (2015). Dependable and Efficient Clinical Molecular Diagnosis of Chinese RP Patient with Targeted Exon Sequencing. PLoS ONE. 10(10). e0140684–e0140684. 18 indexed citations
11.
Huang, Yangmu, Hongliang Dou, Feifei Huang, et al.. (2015). Effect of Supplemental Lutein and Zeaxanthin on Serum, Macular Pigmentation, and Visual Performance in Patients with Early Age-Related Macular Degeneration. BioMed Research International. 2015. 1–8. 56 indexed citations
12.
Huang, Yangmu, Hongliang Dou, Feifei Huang, et al.. (2014). Changes following supplementation with lutein and zeaxanthin in retinal function in eyes with early age-related macular degeneration: a randomised, double-blind, placebo-controlled trial. British Journal of Ophthalmology. 99(3). 371–375. 40 indexed citations
13.
Huang, Yangmu, Le Ma, Zhiyong Zou, et al.. (2013). Serum and macular responses to multiple xanthophyll supplements in patients with early age-related macular degeneration. Nutrition. 29(2). 387–392. 23 indexed citations
14.
Ma, Le, Hongliang Dou, Yangmu Huang, et al.. (2012). Improvement of Retinal Function in Early Age-Related Macular Degeneration After Lutein and Zeaxanthin Supplementation: A Randomized, Double-Masked, Placebo-Controlled Trial. American Journal of Ophthalmology. 154(4). 625–634.e1. 64 indexed citations
15.
Ma, Le, Yangmu Huang, Xinrong Lu, et al.. (2012). Effect of Lutein and Zeaxanthin on Macular Pigment and Visual Function in Patients with Early Age-related Macular Degeneration. Ophthalmology. 119(11). 2290–2297. 139 indexed citations
16.
Ma, Le, Hongliang Dou, Yiqun Wu, et al.. (2011). Lutein and zeaxanthin intake and the risk of age-related macular degeneration: a systematic review and meta-analysis. British Journal Of Nutrition. 107(3). 350–359. 166 indexed citations
17.
Yang, Fan, Hongliang Dou, Zhizhong Ma, et al.. (2010). Serum Inflammatory Factors in Patients with Idiopathic Choroidal Neovascularization. Ocular Immunology and Inflammation. 18(5). 390–394. 8 indexed citations
18.
Ma, Li, Yuling Liu, Zhizhong Ma, et al.. (2009). Targeted Treatment of Choroidal Neovascularization Using Integrin-Mediated Sterically Stabilized Liposomes Loaded With Combretastatin A4. Journal of Ocular Pharmacology and Therapeutics. 25(3). 195–200. 16 indexed citations
19.
Dou, Hongliang, et al.. (2009). Baicalein Reduces Inflammatory Process in a Rodent Model of Diabetic Retinopathy. Investigative Ophthalmology & Visual Science. 50(5). 2319–2319. 131 indexed citations
20.
Wang, Ye-Nan, Lijun Shen, Changguan Wang, et al.. (2007). [Prognosis of traumatic eyes with no light perception undergone vitrectomy and analysis of risk factors].. PubMed. 43(4). 340–5. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by John S. Hurst Breakdown of academic impact, for papers by Eui Seok Shin Breakdown of academic impact, for papers by Ayşegül Çört Breakdown of academic impact, for papers by Maria Hytti Breakdown of academic impact, for papers by Show‐Jen Hong Breakdown of academic impact, for papers by Hiroshi Izuta Breakdown of academic impact, for papers by Özlem Yıldırım Breakdown of academic impact, for papers by Eriko Toda Breakdown of academic impact, for papers by Eveliina Korhonen Breakdown of academic impact, for papers by Daniel A. Gamache
Rankless by CCL
2026